Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register
Authors:
- Christine Bellanné-ChantelotCBChristine Bellanné-Chantelot
- Séverine ClauinSCSéverine Clauin
- Thierry LeblancTLThierry Leblanc
- Bruno CassinatBCBruno Cassinat
- Fernando Rodrigues-LimaFRFernando Rodrigues-Lima
- Sandrine BeaufilsSBSandrine Beaufils
- Christelle VauryCVChristelle Vaury
- Mohamed BarkaouiMBMohamed Barkaoui
- Odile FenneteauOFOdile Fenneteau
- Micheline Maier-RedelspergerMMMicheline Maier-Redelsperger
- Christine ChomienneCCChristine Chomienne
- Jean DonadieuJDJean Donadieu
- 1 June 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (11) , 4119-4125
Abstract
Heterozygous mutations of the gene encoding neutrophil elastase (ELA2) have been associated with cyclic neutropenia (CN) and severe congenital neutropenia (SCN). To date, 30 different mutations have been reported, but no correlation has been found with the degree of neutropenia. To address this issue, we analyzed the clinical, hematologic, and molecular characteristics of 81 unrelated patients with SCN (n = 54) or CN (n = 27). We identified mutations in 31 patients, two thirds of whom had sporadic forms. Familial cases were consistent with dominant inheritance. Seventeen novel mutations were identified, showing that the mutational spectrum encompasses not only the region encoding the mature enzyme but also the prodomains and promoter region. Genotype-phenotype analysis strongly suggested that ELA2 mutations correlate with more severe expression of neutropenia, specifically in patients diagnosed with SCN. This study underlines the importance of ELA2 molecular screening to identify patients who may be at particular risk of severe bacterial infections and/or acute myeloid leukemia/myelodysplasia. By phenotypic analysis of affected relatives and carriers of the same ELA2 mutations, we showed that the expression of neutropenia in CN and SCN may be either homogeneous or variable according to the type of mutations, suggesting different pathogenetic mechanisms.Keywords
This publication has 26 references indexed in Scilit:
- Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastaseNature Genetics, 2003
- Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2Nature Genetics, 2003
- Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropeniaBlood, 2002
- Predicting Changes in the Stability of Proteins and Protein Complexes: A Study of More Than 1000 MutationsJournal of Molecular Biology, 2002
- Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1Nature Genetics, 2002
- Inhibition of Human Neutrophil Elastase. 4. Design, Synthesis, X-ray Crystallographic Analysis, and Structure−Activity Relationships for a Series of P2-Modified, Orally Active Peptidyl Pentafluoroethyl KetonesJournal of Medicinal Chemistry, 1998
- Dominantly inherited severe congenital neutropeniaJournal of Infection, 1996
- [22] Using CLUSTAL for multiple sequence alignments1996
- Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-A resolution.Proceedings of the National Academy of Sciences, 1989
- INFANTILE GENETIC AGRANULOCYTOSISActa Paediatrica, 1975